These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10324213)
1. The importance of patent term restoration to pharmaceutical innovation. Huntt PB Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 10324213 [No Abstract] [Full Text] [Related]
2. Patent term extension: an expensive and unnecessary giveaway. Gore A Health Aff (Millwood); 1982; 1(2):25-33. PubMed ID: 10621692 [No Abstract] [Full Text] [Related]
3. The importance of patent term restoration to small, high technology companies. Kiley TD Health Aff (Millwood); 1982; 1(2):46-52. PubMed ID: 7185722 [No Abstract] [Full Text] [Related]
4. Intellectual property. Balancing innovation and access: patent challenges tip the scales. Higgins MJ; Graham SJ Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944 [No Abstract] [Full Text] [Related]
5. "Obvious to try": a proper patentability standard in the pharmaceutical arts? Trask AV Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581 [No Abstract] [Full Text] [Related]
6. Patents: a threat to innovation? Manocaran M Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557 [No Abstract] [Full Text] [Related]
7. Patent term extension: an overreaching solution to a nonexistent problem. Engelberg AB Health Aff (Millwood); 1982; 1(2):34-45. PubMed ID: 10621693 [No Abstract] [Full Text] [Related]
8. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984. Lewis RA J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987 [No Abstract] [Full Text] [Related]
9. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
10. The importance of patent term restoration to pharmaceutical innovation. Hutt PB Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 7185724 [No Abstract] [Full Text] [Related]
11. The new patent law may accelerate innovation in ophthalmology. Higginbotham EJ; Upadhyay A; Egbuonu-Davis L JAMA Ophthalmol; 2014 Feb; 132(2):137-8. PubMed ID: 24310429 [No Abstract] [Full Text] [Related]
12. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
13. Patent lifecycle management strategies in open innovation projects. Lee Y; Fong EA Drug Discov Today; 2020 Oct; 25(10):1782-1785. PubMed ID: 32592662 [TBL] [Abstract][Full Text] [Related]
16. How Patent Troll Legislation Can Increase Timely Access to Generic Drugs. Treasure CL; Kesselheim AS JAMA Intern Med; 2016 Jun; 176(6):729-30. PubMed ID: 27183456 [No Abstract] [Full Text] [Related]
17. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients. Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613 [TBL] [Abstract][Full Text] [Related]
18. Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives. Altman D; Sweeney C; Yasui T Pharm Pat Anal; 2014 Sep; 3(5):469-73. PubMed ID: 25374314 [No Abstract] [Full Text] [Related]